Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on March 5, 2007

Hypertension. 2007
Published online before print March 5, 2007, doi: 10.1161/HYPERTENSIONAHA.106.080242
A more recent version of this article appeared on May 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/5/1178    most recent
HYPERTENSIONAHA.106.080242v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Munk, V. C.
Right arrow Articles by Battegay, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Munk, V. C.
Right arrow Articles by Battegay, E. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Endothelium/vascular type/nitric oxide

Submitted on September 18, 2006
Revised on October 11, 2006

Angiotensin II Induces Angiogenesis in the Hypoxic Adult Mouse Heart In Vitro Through an AT2-B2 Receptor Pathway

Veronica C. Munk; Lourdes Sanchez de Miguel; Marco Petrimpol; Nicole Butz; Andrea Banfi; Urs Eriksson; Lutz Hein; Rok Humar; and Edouard J. Battegay*

From the Department of Research, Laboratory of Vascular Biology (V.C.M., L.S.d.M., M.P., N.B., R.H., E.J.B.), Medical Outpatient Department (E.J.B.), Department of Research and Department of Surgery, Cell and Gene Therapy (A.B.), and Department of Research, Experimental Critical Care (U.E.), University Hospital, Basel, Switzerland; and Institut für Experimentelle und Klinische Pharmakologie und Toxikologie (L.H.), Freiburg, Germany.

* To whom correspondence should be addressed. E-mail: ebattegay{at}uhbs.ch.

Abstract--Angiotensin II is a vasoactive peptide that may affect vascularization of the ischemic heart via angiogenesis. In this study we aimed at studying the mechanisms underlying the angiogenic effects of angiotensin II under hypoxia in the mouse heart in vitro. Endothelial sprout formation from pieces of mouse hearts was assessed under normoxia (21% O2) and hypoxia (1% O2) during a 7-day period of in vitro culture. Only under hypoxia did angiotensin II dose-dependently induce endothelial sprout formation, peaking at 10-7 mol/L of angiotensin II. Angiotensin II type 1 (AT1) receptor blockade by losartan did not affect angiotensin II-induced sprouting in wild-type mice. Conversely, the angiotensin II type 2 (AT2) receptor antagonist PD 123319 blocked this response. In hearts from AT1-/- mice, angiotensin II-elicited sprouting was preserved but blocked again by AT2 receptor antagonism. In contrast, no angiotensin II-induced sprouting was found in preparations from hearts of AT2-/- mice. Angiotensin II-mediated angiogenesis was also abolished by a specific inhibitor of the B2 kinin receptor in both wild-type and AT1-/- mice. Furthermore, angiotensin II failed to induce endothelial sprout formation in hearts from B2-/- mice. Finally, NO inhibition completely blunted sprouting in hearts from wild-type mice, whereas NO donors could restore sprouting in AT2-/- and B2-/- hearts. This in vitro study suggests the obligatory role of hypoxia in the angiogenic effect of angiotensin II in the mouse heart via the AT2 receptor through a mechanism that involves bradykinin, its B2 receptor, and NO as a downstream effector.


Key words: heart • angiotensin II • bradykinin • losartan • nitric oxide




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
C. Clapp, S. Thebault, M. C. Jeziorski, and G. Martinez De La Escalera
Peptide Hormone Regulation of Angiogenesis
Physiol Rev, October 1, 2009; 89(4): 1177 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Sanchez de Miguel, S. Neysari, S. Jakob, M. Petrimpol, N. Butz, A. Banfi, C. E. Zaugg, R. Humar, and E. J. Battegay
B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart
Cardiovasc Res, October 1, 2008; 80(1): 106 - 113.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Hu, A. Dandapat, and J. L Mehta
Angiotensin II Induces Capillary Formation From Endothelial Cells Via the LOX-1 Dependent Redox-Sensitive Pathway
Hypertension, November 1, 2007; 50(5): 952 - 957.
[Abstract] [Full Text] [PDF]